Top

Industries Fearing a Port Strike Urge Biden to Revive Talks

Volkswagen Likely to Wind Down Its Xinjiang Investments over Forced Labor Concerns

FTC Announces Largest-Ever Civil Penalty for Made in USA Labeling Fraud

Treasury Secretary Yellen Outlines U.S.-China Relationship Objectives for 2024

90% of Energy Companies Experienced 3rd Party Breach

Tag: Nanoscope Therapeutics Inc

Industry Focus Areas, Medical

Nanoscope Awarded Key U.S. Patent Protecting its Multi-Characteristic Opsin Gene Therapy Platform For Reversing Blindness

January 10, 2022

Via: PR Newswire

Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing optogenetic gene therapies for retinal degenerative diseases, today announced that Nanoscope has been awarded U.S. patent 11,180,537 covering its Multi-Characteristic Opsin (MCO) optogenetic gene therapy platform for restoring vision. This award bolsters […]